Examining U.S. Drug Pricing Disparities

This chapter explores the significant price differences of prescription drugs in the U.S. versus other countries, focusing on hidden factors such as employer-sponsored insurance and the implications of Trump's 'most favored nation' executive order. It highlights the complexities of the healthcare system, the influence of pharmaceutical companies, and the need for patent law reform to enhance competition and lower drug prices.